Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$3.81 - $6.76 $52,208 - $92,632
13,703 Added 116.09%
25,507 $105,000
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $121 - $257
20 Added 0.17%
11,804 $71,000
Q2 2022

Aug 15, 2022

SELL
$8.35 - $21.89 $7.11 Million - $18.6 Million
-851,970 Reduced 98.64%
11,784 $123,000
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $1.75 Million - $3.29 Million
-102,910 Reduced 10.65%
863,754 $17.8 Million
Q4 2021

Feb 14, 2022

SELL
$25.61 - $41.78 $96,933 - $158,137
-3,785 Reduced 0.39%
966,664 $30.2 Million
Q3 2021

Nov 16, 2021

SELL
$19.65 - $27.99 $47,258 - $67,315
-2,405 Reduced 0.25%
970,449 $22.6 Million
Q2 2021

Aug 16, 2021

SELL
$17.48 - $25.46 $365,908 - $532,954
-20,933 Reduced 2.11%
972,854 $22 Million
Q1 2021

May 17, 2021

SELL
$18.08 - $28.8 $7.8 Million - $12.4 Million
-431,291 Reduced 30.26%
993,787 $22.7 Million
Q4 2020

Feb 16, 2021

SELL
$11.7 - $23.41 $1.22 Million - $2.45 Million
-104,692 Reduced 6.84%
1,425,078 $31.1 Million
Q3 2020

Nov 16, 2020

BUY
$11.21 - $13.82 $412,684 - $508,769
36,814 Added 2.47%
1,529,770 $18 Million
Q2 2020

Aug 14, 2020

BUY
$9.8 - $12.77 $113,670 - $148,119
11,599 Added 0.78%
1,492,956 $17 Million
Q1 2020

May 14, 2020

SELL
$8.78 - $18.6 $184,819 - $391,530
-21,050 Reduced 1.4%
1,481,357 $16.5 Million
Q4 2019

Feb 18, 2020

BUY
$13.12 - $17.06 $2.82 Million - $3.67 Million
215,140 Added 16.71%
1,502,407 $24 Million
Q3 2019

Nov 14, 2019

BUY
$12.75 - $19.01 $3.86 Million - $5.76 Million
302,908 Added 30.77%
1,287,267 $17.7 Million
Q2 2019

Jul 31, 2019

SELL
$17.0 - $21.88 $36,448 - $46,910
-2,144 Reduced 0.22%
984,359 $18.1 Million
Q1 2019

Apr 30, 2019

SELL
$15.53 - $22.15 $620,190 - $884,560
-39,935 Reduced 3.89%
986,503 $20.3 Million
Q4 2018

Feb 06, 2019

BUY
$14.06 - $22.57 $14.4 Million - $23.2 Million
1,026,438 New
1,026,438 $17.1 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.